1. AB0195 Type 2 Innate Lymphoid Cell Counts Are Increased in Patients with Systemic Sclerosis and Correlate with the Extent of Fibrosis. (9th June 2015) Authors: Wohlfahrt, T.; Usherenko, S.; Dees, C.; Palumbo-Zerr, K.; Beyer, C.; Gelse, K.; Distler, O.; Schett, G.; Distler, J.H.; Ramming, A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0407 Dipeptidyl-peptidase-4 (DPP4) is a potential new molecular target for treatment of fibrosis. (12th June 2018) Authors: Soare, A.M.; Györfy, H.; Matei, A.; Dees, C.; Zhang, Y.; Wohlfahrt, T.; Chen, C.-W.; Ramming, A.; Schett, G.; Distler, J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0410 TgfΒ promotes fibrosis by myst1-dependent epigenetic regulation of autophagy. (12th June 2018) Authors: Zehender, A.; Lin, N.-Y.; Stefanica, A.; Chen, C.-W.; Soare, A.; Wohlfahrt, T.; Rauber, S.; Bergmann, C.; Ramming, A.; Distler, O.; Distler, J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0051 Dipeptidyl-Peptidase-4 (DPP4) Characterizes A Subpopulation of Fibrosis-Promoting Fibroblasts and Is A Molecular Target for The Treatment of Fibrosis. (15th July 2016) Authors: Soare, A.M.; Dees, C.; Zhang, Y.; Liang, R.; Wohlfahrt, T.; Rauber, S.; Lin, N.; Chen, C.-W.; Ramming, A.; Distler, O.; Mihai, C.; Schett, G.; Distler, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0141 HIGH DIMENSIONAL ANALYSIS REVEAL A NETWORK OF CERTAIN TRANSCRIPTION FACTORS THAT LINK VASCULOPATHY AND ORGAN FIBROSIS IN SYSTEMIC SCLEROSIS. (2nd June 2020) Authors: Anchang, C. G.; Matalobos Lawaree, B.; Weber, S.; Rauber, S.; Wohlfahrt, T.; Luber, M.; Kreuter, A.; Schett, G.; Distler, J.; Ramming, A. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0021 Type 2 Innate Lymphoid Cells Are Rapidly and Persistently Recruited in Experimental Fibrosis and Their Counts Correlate with The Severity of Skin and Lung Fibrosis in Systemic Sclerosis. (15th July 2016) Authors: Wohlfahrt, T.; Weber, S.; Englbrecht, M.; Dees, C.; Beyer, C.; Distler, O.; Schett, G.; Distler, J.; Ramming, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0186 The Homeoprotein Engrailed-1 Regulates Canonical TGF-β Signaling via Fibroblast Differentiation and Tissue Fibrosis. (15th July 2016) Authors: Mallano, T.; Palumbo-Zerr, K.; Beyer, C.; Dees, C.; Huang, J.; Wohlfahrt, T.; Distler, O.; Schett, G.; Distler, J.H. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗